Kathleen Kolaski to Humans
This is a "connection" page, showing publications Kathleen Kolaski has written about Humans.
Connection Strength
0.427
-
Kolaski K. Which antiepileptic drugs are safe and effective as monotherapy to treat focal and generalized seizures in adults and children? A Cochrane Review summary with commentary. Dev Med Child Neurol. 2023 Feb; 65(2):158-161.
Score: 0.050
-
Kolaski K. Is chloral hydrate effective and safe as a sedating agent for neurodiagnostic procedures in children? A Cochrane Review summary with commentary. Dev Med Child Neurol. 2022 Aug; 64(8):941-943.
Score: 0.048
-
Kolaski K. Are anti-seizure medications effective and safe treatments for Lennox-Gastaut syndrome? A Cochrane Review summary with commentary. Dev Med Child Neurol. 2022 Jun; 64(6):678-680.
Score: 0.047
-
Romeiser Logan L, Kolaski K. Guideline to improve physical function in cerebral palsy: too big to succeed. Dev Med Child Neurol. 2022 May; 64(5):662-663.
Score: 0.047
-
Kolaski K, Romeiser Logan L, Goss KD, Butler C. Quality appraisal of systematic reviews of interventions for children with cerebral palsy reveals critically low confidence. Dev Med Child Neurol. 2021 Nov; 63(11):1316-1326.
Score: 0.045
-
Kim H, Kolaski K. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary. NeuroRehabilitation. 2021; 49(1):161-164.
Score: 0.044
-
Kolaski K. Are Communication Interventions Effective for Minimally Verbal Children with Autism Spectrum Disorder? A Cochrane Review Summary with Commentary. Dev Neurorehabil. 2020 11; 23(8):557-559.
Score: 0.043
-
Kolaski K. Botulinum toxin: did the black box warning change how we treat children with cerebral palsy? Dev Med Child Neurol. 2018 05; 60(5):440-441.
Score: 0.036
-
Kolaski K, Ajizian SJ, Passmore L, Pasutharnchat N, Koman LA, Smith BP. Safety profile of multilevel chemical denervation procedures using phenol or botulinum toxin or both in a pediatric population. Am J Phys Med Rehabil. 2008 Jul; 87(7):556-66.
Score: 0.018
-
Kolaski K, Logan LR. A review of the complications of intrathecal baclofen in patients with cerebral palsy. NeuroRehabilitation. 2007; 22(5):383-95.
Score: 0.017
-
Kolaski K. Use of intrathecal baclofen in a child with spastic paraparesis related to human immunodeficiency virus infection: A case report. Arch Phys Med Rehabil. 2006 Jul; 87(7):1001-3.
Score: 0.016
-
Wiart L, Kolaski K, Butler C, Vogtle L, Logan LR, Hickman R, Romeiser J, Samson-Fang L, Matsuba CA, Baird MW, Roxborough L, Mayson T, Dinu I. Interrater reliability and convergent validity of the American Academy for Cerebral Palsy and Developmental Medicine methodology for conducting systematic reviews. Dev Med Child Neurol. 2012 Jul; 54(7):606-11.
Score: 0.006
-
Kesar TM, Sawaki L, Burdette JH, Cabrera MN, Kolaski K, Smith BP, O'Shea TM, Koman LA, Wittenberg GF. Motor cortical functional geometry in cerebral palsy and its relationship to disability. Clin Neurophysiol. 2012 Jul; 123(7):1383-90.
Score: 0.006
-
Seyler TM, Smith BP, Marker DR, Ma J, Shen J, Smith TL, Mont MA, Kolaski K, Koman LA. Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience. J Bone Joint Surg Am. 2008 Nov; 90 Suppl 4:133-45.
Score: 0.005